AndrewDavidBarretoMD

Neurology • Houston, TX

Vascular Neurology

Associate Professor, Neurology, UTHealth-- McGovern School of Medicine at the University of Texas Health Science Center at Houston

Join to view full profile

Dr. Barreto is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Barreto's full profile

Already have an account?

Office
Ut Physicians Neurology
6410 Fannin St Ste 1014
Houston, TX 77030
Phone+1 832-325-7083

Fax+1 713-500-0638

Education & Training

University of Texas Health Science Center at HoustonMS, Clinical Research, 2014
University of Texas Health Science Center at HoustonFellowship, Vascular Neurology, 2006 - 2008
University of Alabama Medical CenterResidency, Neurology, 2003 - 2006
University of MarylandInternship, Internal Medicine, 2002 - 2003
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2002

Certifications & Licensure

TX State Medical License 2006 - 2025
AL State Medical License 2004 - 2018
LA State Medical License 2010 - 2017
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Vascular Neurology

Clinical Trials

Argatroban Stroke Treatment - A Pilot Safety Study Start of enrollment: 2003 Feb 01
Completed
Phase 1, Phase 2
Safety of Intravenous Thrombolysis for Wake-up Stroke Start of enrollment: 2010 Jul 01
Completed
Phase 2
Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke Start of enrollment: 2011 Oct 01
Terminated
Phase 2
Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke Start of enrollment: 2015 May 01
Completed
Phase 2
SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke Start of enrollment: 2018 Jul 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

127 citations
Outcomes of Endovascular Thrombectomy vs Medical Management Alone in Patients With Large Ischemic Cores: A Secondary Analysis of the Optimizing Patient's Selection for...
Amrou Sarraj, Ameer E Hassan, Sean I Savitz, Clark Sitton, James C. Grotta
JAMA Neurology. 2019-10-01
19 citations
Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator for Emergent Revascularization in Acute Ischemic Stroke (Clotbust-ER): Design and ...
Peter D. Schellinger, Andrei V. Alexandrov, Andrew D Barreto, Andrew M. Demchuk, Georgios Tsivgoulis
International Journal of Stroke. 2015-06-29
53 citations
Optimizing Patient Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT): A Prospective, Multicenter Cohort Study of Imaging Selection.
Amrou Sarraj, Ameer E Hassan, James C. Grotta, Clark Sitton, Gary Cutter
Annals of Neurology. 2020-03-01

Lectures

Clinical Trials of Direct Thrombin Inhibitors for Stroke - Focus on Argatroban
Houston, TX - 2/13/2014

Press Mentions

Central DuPage's Mobile Unit Will Treat Strokes on the RoadJanuary 3rd, 2017
UTHealth: Clot-Busting Medication Safe for Patients Who Wake up with StrokeSeptember 19th, 2016
Clot-Busting Drug May Be Safe for Those with 'Wake-Up' Strokes - US NewsFebruary 12th, 2015
Join now to see all